These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11495486)

  • 61. Protein stability during nebulization: Mind the collection step!
    Bodier-Montagutelli E; Respaud R; Perret G; Baptista L; Duquenne P; Heuzé-Vourc'h N; Vecellio L
    Eur J Pharm Biopharm; 2020 Jul; 152():23-34. PubMed ID: 32289493
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide.
    Lange CF; Hancock RE; Samuel J; Finlay WH
    J Pharm Sci; 2001 Oct; 90(10):1647-57. PubMed ID: 11745723
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aerosols for systemic treatment.
    Köhler D
    Lung; 1990; 168 Suppl(Suppl 1):677-84. PubMed ID: 2117179
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A simple device for the exposure of animals to infectious microorganisms by the airborne route.
    Phillpotts RJ; Brooks TJ; Cox CS
    Epidemiol Infect; 1997 Feb; 118(1):71-5. PubMed ID: 9042037
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aerosolized antimicrobial therapy in acutely ill patients.
    Wood GC; Boucher BA
    Pharmacotherapy; 2000 Feb; 20(2):166-81. PubMed ID: 10678295
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Factors to consider when selecting a nebulizer for a new inhaled drug product development program.
    Elphick M; von Hollen D; Pritchard JN; Nikander K; Hardaker LE; Hatley RH
    Expert Opin Drug Deliv; 2015 Aug; 12(8):1375-87. PubMed ID: 25758911
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhaled therapeutics for prevention and treatment of pneumonia.
    Safdar A; Shelburne SA; Evans SE; Dickey BF
    Expert Opin Drug Saf; 2009 Jul; 8(4):435-49. PubMed ID: 19538104
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhaled nintentanib, pirfenidone and macitentan for pulmonary fibrosis: a laboratory experiment.
    Zarogoulidis P; Petridis D; Huang H; Bai C; Oikonomou P; Nikolaou C; Matthaios D; Perdikouri EI; Papadopoulos V; Petanidis S; Kosmidis C; Charalampidis C; Hohenforst-Schmidt W; Kougkas N; Sardeli C
    Ther Deliv; 2023 Aug; 14(8):491-498. PubMed ID: 37584210
    [No Abstract]   [Full Text] [Related]  

  • 69. Clinical experimentation with aerosol antibiotics: current and future methods of administration.
    Zarogoulidis P; Kioumis I; Porpodis K; Spyratos D; Tsakiridis K; Huang H; Li Q; Turner JF; Browning R; Hohenforst-Schmidt W; Zarogoulidis K
    Drug Des Devel Ther; 2013; 7():1115-34. PubMed ID: 24115836
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Optimizing nebulization practice.
    Burnett H
    Respir Med; 1996 May; 90(5):315-6. PubMed ID: 9499818
    [No Abstract]   [Full Text] [Related]  

  • 71. In vitro-in vivo correlation of pharmaceutical aerosols.
    Hickey AJ; Kwok PCL
    Adv Drug Deliv Rev; 2021 Dec; 179():114025. PubMed ID: 34710531
    [No Abstract]   [Full Text] [Related]  

  • 72. Promoting adherence to inhaled therapy: building partnerships through patient education.
    Lewis RM; Fink JB
    Respir Care Clin N Am; 2001 Jun; 7(2):277-301, vi. PubMed ID: 11517024
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aerosol evaluations of the DeVilbiss No. 40 and Vaponefrin nebulizers.
    Larson EW; Young HW; Walker JS
    Appl Environ Microbiol; 1976 Jan; 31(1):150-1. PubMed ID: 942205
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel mask to prevent aerosol spread during nebulization treatment.
    Kao CL; Lin CH
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):769-771. PubMed ID: 32792205
    [No Abstract]   [Full Text] [Related]  

  • 75. [Effect of particular type of nebulizer on the activity and duration of bactericidal power of aerosols of certain disinfectants].
    LUGLI AM
    Riv Ital Ig; 1952; 12(5-6):182-6. PubMed ID: 12994650
    [No Abstract]   [Full Text] [Related]  

  • 76. [Administration of anti-infective agents through the inhaled route].
    Clemente Bautista S; Fernández Polo A; Gil Luján G; Cabañas Poy MJ; Oliveras Arenas M; Hidalgo Albert E
    Farm Hosp; 2007; 31(2):112-9. PubMed ID: 17590120
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Aprotinin antiviral aerosol: study of the local irritating and allergenic action after inhalation].
    Zhirnov OP; Ovcharenko AV; Goliando PB; Svinogeeva TP; Dolgova GV; Nikitin AV
    Antibiot Khimioter; 1994; 39(9-10):54-8. PubMed ID: 7535043
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Aerosol therapy with thiamphenicol glycinate: a retrospective study on efficacy and safety in a group of sixty-six oncological patients.
    Macchi A; Terranova P; Macchi S; Roselli R; Castelnuovo P
    Int J Immunopathol Pharmacol; 2011; 24(1):189-93. PubMed ID: 21496402
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Aerosol Society Drug Delivery to the Lungs VIII. London, United Kingdom, December 15-16, 1997. Abstracts.
    J Aerosol Med; 1998; 11(3):175-91. PubMed ID: 10186962
    [No Abstract]   [Full Text] [Related]  

  • 80. [New model of nebulizer with device for varying the micelle].
    GRAU VILARRUBIAS J
    Rev Med Chil; 1950 Aug; 78(8):538-9. PubMed ID: 14776300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.